Here, we present a case of a patient with advanced SqCLC that harbors not only CDKN2A mutation, and PIK3CA amplification, but also Tumor mutational burden High (TMB-H) and a tumor proportional score (TPS) of 50%. This evidence concerns the gene CDKN2A and neoplasm.